# Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months

> **NCT07507500** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz** · enrollment: 8100 (estimated)

## Conditions studied

- Myocardial Infarction (MI)

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT07507500
- **Lead sponsor:** Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2029-07
- **Final completion:** 2030-01
- **Target enrollment:** 8100 (ESTIMATED)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07507500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07507500, "Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT07507500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*